...
【24h】

Biopsy of Liver Target Lesions under Contrast-Enhanced Ultrasound Guidance – A Multi-Center Study

机译:对比度增强超声引导下肝脏靶病变的活检 - 一种多中心研究

获取原文
获取原文并翻译 | 示例

摘要

Purpose To retrospectively characterize the prevalence and impact of contrast-enhanced ultrasound (CEUS) as a guidance technique for the biopsy of liver target lesions (LTLs) at six interventional ultrasound centers. Materials and Methods The six participating centers retrospectively selected all patients in whom biopsy needles were positioned in LTLs during CEUS. The prevalence of CEUS-guided biopsies at each center between 2005 and 2016, contrast agent consumption, procedure indications, diagnostic yield and complications were assessed. Informed consent was obtained for all patients. Results CEUS-guided biopsy of LTLs was carried out in 103 patients (68 M/35 F, median age: 69 yrs) with 103 liver target lesions (median size: 20 mm) using cutting needles (18 – 20 g) in 94 cases (91.2 %). CEUS-guided biopsy represented 2.6 % (range: 0.8 – 7.7 %) of 3818 biopsies on LTLs carried out at the participating centers. Indications to CEUS-guided biopsy were: a target lesion not visible on non-enhanced US (27.2 %), improvement of conspicuity of the target (33 %), choice of non-necrotic area inside the target (39.8 %). 26 patients (25.2 %) had a previously non-diagnostic cyto-histological exam. The diagnostic accuracy of the technique was 99 %. No major complications followed infusion of contrast agent or biopsy performance. Conclusion The indications for CEUS-guided biopsy for LTLs are limited, but CEUS can be useful in challenging clinical scenarios, e. g. poorly visualized or invisible lesions or sampling of non-necrotic areas in the target lesions. There is also a potential advantage in using CEUS to guide repeat biopsies after unsuccessful sampling performed using the standard ultrasound technique.
机译:目的要回顾性地表征对比度增强超声(CEU)作为六个介入超声中心肝脏靶病变(LTLS)活检的引导技术的引导技术。材料和方法六个参与中心回顾性地选择了在CEUS期间在LTL中定位活检针的所有患者。在2005年至2016年间,每中心的Ceus引导活检的患病率,评估了造影剂消费,程序适应症,诊断产量和并发症。所有患者都获得了知情同意。结果LTLS的Ceus引导活检是在103名患者(68米/ 35°F,中位数:69 YR)中进行了103例肝脏靶位病变(中位数:20 mm),使用切割针(18-20g),94例(91.2%)。在参与中心进行的LTL上,Ceus引导的活组织检查代表2.6%(范围:0.8-7.7%)3818个活组织检查。引发审计的活检的适应症是:在非增强的美国(27.2%)上不可见的靶病变,靶标的链接性(33%),在目标内的非坏死区域的选择(39.8%)。 26名患者(25.2%)具有先前未诊断的细胞组织学检查。该技术的诊断准确性为99%。没有重症并发症遵循造影剂或活检性能的输注。结论LTLS的CEUS引导活检的适应症是有限的,但CEUS可用于具有挑战性的临床情景,E。 G。可视化或无形的病变或靶病变中非坏死区域的取样。使用CEUS在使用标准超声技术执行不成功的采样后引导重复活检的潜在优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号